| 发明名称 |
MONOCLONAL ANTIBODY ZT/2F2 IN TARGETED THERAPY OF CANCERS OVEREXPRESSING THE RON RECEPTOR TYROSINE KINASE |
| 摘要 |
A method for treating a patient is provided. In accordance with the method, a suitable dosage of a pharmaceutical composition is applied to the patient, wherein the pharmaceutical composition comprises an antibody that binds to the RON receptor along a portion of its amino acid sequence identified by (SEQ ID NO: 1). |
| 申请公布号 |
WO2010014751(A3) |
申请公布日期 |
2010.05.06 |
| 申请号 |
WO2009US52155 |
申请日期 |
2009.07.29 |
| 申请人 |
TEXAS TECH UNIVERSITY;WANG, MING-HAI;YAO, HANG-PPING |
发明人 |
WANG, MING-HAI;YAO, HANG-PPING |
| 分类号 |
A61K39/395;A61P35/00 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
